Medicine and Dentistry
Acute Kidney Injury
70%
Direct Oral Anticoagulant
70%
Chronic Kidney Disease
70%
COVID-19
52%
Atrial Fibrillation
52%
Anticoagulation
48%
Antithrombotic
41%
Drug Therapy
39%
Kidney Graft
35%
Peritoneal Dialysis
35%
Hemodialysis
35%
Anticoagulant Therapy
35%
Shared Decision Making
35%
Venous Thromboembolism
22%
Nephropathy
16%
Intensive Care
15%
End Stage Renal Disease
15%
Thromboembolism
12%
Anticoagulant
12%
Reducing Agent
11%
Artificial Respiration
11%
Kidney Function
10%
Bleeding
10%
Renal Replacement Therapy
7%
Diseases
7%
Severe Renal Impairment
7%
Clinician
7%
Decision Making
7%
Urinary Excretion
7%
Medication Compliance
5%
Prevalence
5%
Cross-Validation
5%
Population
5%
Apixaban
5%
Rivaroxaban
5%
Ciclonicate
5%
Vitamin K Antagonist
5%
Nursing and Health Professions
Acute Kidney Failure
88%
Kidney Disease
81%
Anticoagulant Agent
54%
Chronic Kidney Failure
52%
Anticoagulation
41%
Drug Therapy
39%
Pill
35%
Hemodialysis
35%
Atrial Fibrillation
35%
Anticoagulant Therapy
35%
Shared Decision-Making
35%
Health Care Personnel
17%
Kidney Graft
17%
Peritoneal Dialysis
16%
Intensive Care
15%
End Stage Renal Disease
15%
Artificial Respiration
11%
Disease
11%
Comorbidity
9%
World Health Organization
7%
Renal Replacement Therapy
7%
Practice Guideline
7%
Population
5%
Prevalence
5%
Thromboembolism
5%
Reducing Agent
5%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Acute Kidney Failure
70%
Atrial Fibrillation
63%
Chronic Kidney Failure
57%
Kidney Disease
46%
Hemodialysis
42%
Comorbidity
39%
Reducing Agent
35%
Venous Thromboembolism
35%
Direct Oral Anticoagulant
21%
Warfarin
21%
Cross-Validation
17%
End Stage Renal Disease
15%
Bleeding
14%
Disease
11%
Replacement Therapy
7%
Cohort Study
7%
Apixaban
7%
Severe Renal Impairment
7%
Low Molecular Weight Heparin
7%
Prevalence
5%
Thromboembolism
5%